Compare IRS & PRCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
IRSA Inversiones Y Representaciones S.A. Global Depositary Shares (Each representing ten shares of)
Current Price
Current Price
| Metric | IRS | PRCT |
|---|---|---|
| Founded | 1943 | 2009 |
| Country | Argentina | United States |
| Employees | 1392 | N/A |
| Industry | Homebuilding | Medical Specialities |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.3B |
| IPO Year | N/A | 2021 |
| Metric | IRS | PRCT |
|---|---|---|
| Price | $15.50 | $26.48 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 11 |
| Target Price | N/A | ★ $35.44 |
| AVG Volume (30 Days) | 154.1K | ★ 1.5M |
| Earning Date | 05-07-2026 | 04-29-2026 |
| Dividend Yield | ★ 9.85% | N/A |
| EPS Growth | N/A | ★ 1.71 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $308,054,000.00 |
| Revenue This Year | N/A | $31.34 |
| Revenue Next Year | N/A | $24.52 |
| P/E Ratio | $3.66 | ★ N/A |
| Revenue Growth | N/A | ★ 37.22 |
| 52 Week Low | $10.87 | $19.35 |
| 52 Week High | $19.14 | $64.89 |
| Indicator | IRS | PRCT |
|---|---|---|
| Relative Strength Index (RSI) | 58.78 | 50.93 |
| Support Level | $13.77 | $24.85 |
| Resistance Level | $15.64 | $29.07 |
| Average True Range (ATR) | 0.61 | 1.84 |
| MACD | 0.24 | -0.01 |
| Stochastic Oscillator | 90.30 | 34.07 |
IRSA Inversiones y Representaciones SA is engaged in a diversified business. The company's operating segments include Shopping Malls, which comprise lease and service revenues principally related to the rental of commercial and other spaces in the company's shopping malls; Offices, which include lease revenues and other service revenues related to office activities; Sales and Developments, which include the development, maintenance, and sales of undeveloped parcels of land and/or trading properties; Hotels, which mainly include revenues from rooms, catering, and restaurants; and others. The company generates the majority of its revenue from the Shopping Malls segment.
PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. The company develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.